PORTLAND, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a manufacturer of medical diagnostic tests for the rapid detection of antibodies to the human immunodeficiency virus (HIV), announced today that it has established a branch office in Geneva, Switzerland to expand the Company’s relationships with International Organizations, as well as market its diagnostic tests to Europe, Central Asia and French-speaking Africa. The Company named experienced executives Khatuna Janjalia, President and Kartlos Edilashvili, Vice President of the Geneva Branch Office.
